# DESCRIPTION

## BACKGROUND OF THE INVENTION

### 1. Field of the Invention

- relate to method and kit for evaluating prognosis in patient with breast cancer

### 2. The Prior Art

- describe limitations of current methods for evaluating prognosis in breast cancer
- motivate need for new method and kit

## SUMMARY OF THE INVENTION

- introduce method for evaluating prognosis in patient with breast cancer
- describe steps of method
- specify pyruvate kinase isoenzyme M2 (PKM2) as pyruvate kinase
- specify luminal breast cancer as type of breast cancer
- specify hormone receptor (HR) positive and human epidermal growth factor receptor type 2 (HER2) negative as characteristics of breast cancer
- introduce kit for evaluating prognosis in patient with breast cancer
- summarize advantages of method and kit

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

- provide detailed description of embodiments of method and kit

### Definition

- define data representation
- define high expression levels of PKM2 and O-GlcNAc
- define clinical treatment score post-5 years (CTS5)

### High Expression of Pyruvate Kinase Isoenzyme M2 (PKM2) is Associated With Poor Clinical Outcome in Luminal Breast Cancer

- describe protocol approval and informed consent
- describe patient selection and characteristics
- describe PKM2 expression analysis
- describe survival analysis
- summarize results

### High Expression of O-Linked Î²-N-Acetylglucosamine (O-GlcNAc) and PKM2 Can Predict Poor Prognosis of HR+/HER2- Breast Cancer

- describe IHC assessment procedure
- describe patient selection and characteristics
- describe O-GlcNAc and PKM2 expression analysis
- describe Q score calculation
- describe Kaplan-Meier analysis
- describe luminal A and luminal B subtype analysis
- describe O-GlcNAc and PKM2 expression association with recurrence
- describe Kaplan-Meier survival analysis
- describe DFS analysis
- describe combined double-marker status analysis
- describe DFS curve diagram
- summarize results

### Logistic Regression and Receiver Operating Characteristic (ROC) Curve Analysis

- describe logistic regression analysis
- describe ROC curve analysis
- describe combined PKM2-O-GlcNAc-CTS5 model
- summarize results

